In Brief: FDA Vaccines & Related Biological Products Advisory Committee
Executive Summary
FDA Vaccines & Related Biological Products Advisory Committee: Jan. 29-31 meeting has been moved from FDA's Parklawn Building to the Doubletree Hotel in Rockville, Md. The committee will review Behringwerke's rabies vaccine, Connaught's DaPT vaccine for an infant indication, influenza vaccine formulations for 1996-97, sequential IPV/OPV schedules and Merck's hepatitis A vaccine Vaqta ("The Pink Sheet" Jan. 1, In Brief)...